← Back to Patent Explorer
US4845125A Expired / Lapsed US ⏱️ 0.0 years remaining

Chemolytic EDTA-citric acid composition for dissolution of calculi

Assignee: INDIANAPOLIS CENTER FOR ADVANCED RESEARCH Inc 611 NORTH CAPITOL AVENUE INDIANAPOLIS INDIANA 46204 A CORP OF
•
Filing: 1987-11-10
•
Granted: 1989-07-04
•
Expires: 2007-11-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved composition for dissolution of renal calculi is disclosed. The composition includes citric acid, preferably at about 10 to about 15% by weight, and an effective amount of a pharmacologically acceptable chelating agent such as EDTA in a sterile aqueous solution having a pH between about 3 and about 4.5. In vivo irrigation with the improved formulation, optionally in combination with incident ultrasound therapy promotes rapid stone dissolution with minimal complications for the patient.

Inventors

  • 👤 George E. Geier

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 22:24
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/195

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 63 words
A chemolytic composition for in vivo dissolution of calculi comprising about 5 to about 20% citric acid or a pharmacologically acceptable salt thereof; and a chelating agent selected from the group consisting of ethylenediaminetetraacetic acid, N-(hydroxyethyl)ethylenediaminetriacetic acid and nitrilotriacetic acid at a concentration of at least about 0.05 M, in a sterile aqueous medium at a pH between about 3 and about 4.5.
Claim 2
Dependent Claim 63 words
A chemolytic composition for in vivo dissolution of calculi comprising about 5 to about 20% citric acid or a pharmacologically acceptable salt thereof; and a chelating agent selected from the group consisting of ethylenediaminetetraacetic acid, N-(hydroxyethyl)ethylenediaminetriacetic acid and nitrilotriacetic acid at a concentration of at least about 0.05 M, in a sterile aqueous medium at a pH between about 3 and about 4.5.
Claim 3
Dependent Claim 14 words
The chemolytic composition of claim 1 containing about 10 to about 15% citric acid.
Claim 4
Dependent Claim 13 words
The chemolytic composition of claim 2 wherein the chelating agent is ethylenediaminetetraacetic acid.
Claim 5
Dependent Claim 18 words
The chemolytic composition of claim 3 wherein the pH is adjusted to between about 3.5 and about 4.
Claim 6
Dependent Claim 20 words
A method of dissolving struvite kidney stones comprising contact said stones with a chemolytic composition in accordance with claim 4.
Claim 7
Dependent Claim 22 words
The method in accordance with claim 5 wherein the kidney stones are contacted with said compositions in the presence of incident ultrasound.
Claim 8
Dependent Claim 20 words
A method of dissolving struvite kidney stones comprising contacting said stones with a chemolytic composition with accordance with claim 4.
Claim 9
Dependent Claim 20 words
The method of claim 7 wherein the kidney stones are contacted with said composition in the presence of incident ultrasound.
Claim 10
Dependent Claim 20 words
A method of dissolving calculi (kidney stones) comprising contacting said stone with a chemolytic composition in accordance with claim 1.
Claim 11
Dependent Claim 20 words
The method of claim 9 wherein the kidney stones are contacted with said composition in the presence of incident ultrasound.
Claim 12
Dependent Claim 65 words
In a chemolytic stern aqueous solution adapted for dissolution of struvite kidney stones and containing citric acid, the improvement which comprises adjusting the concentration of said citric acid to about 10 to about 15% by weight of said solution and adding the chelating agent ethylenediaminetetraacetic acid to a concentration of about 0.05 to about 0.20 M, said solution having a pH between 3 and 4.5.
Claim 13
Dependent Claim 65 words
In a chemolytic stern aqueous solution adapted for dissolution of struvite kidney stones and containing citric acid, the improvement which comprises adjusting the concentration of said citric acid to about 10 to about 15% by weight of said solution and adding the chelating agent ethylenediaminetetraacetic acid to a concentration of about 0.05 to about 0.20 M, said solution having a pH between 3 and 4.5.
Claim 14
Dependent Claim 20 words
The improvement of claim 11 wherein the pH of the solution is adjusted to between about 3.5 and about 4.0.
Claim 15
Dependent Claim 23 words
The improvement of claim 12 wherein the citric acid concentration is about 12% by weight, and the EDTA concentration is about 0.1 M.

References Cited (Backward Citations)

US3184381A Cited
US3328304A Cited
US3492238A Cited
US3838196A Cited
US4276185A Cited
DE3046580A1 Cited
US4637899A Cited
JPS60197624A Cited
US4682600A Cited
JPS62127484A Cited
US4708805A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-07-03 1993-01-02 1993-07-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-07-03 1997-01-02 1997-07-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-07-03 2001-01-02 2001-07-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag